Non-invasive assessment of skin barrier integrity and skin irritation following iontophoretic current application in humans

Journal of Controlled Release

Volumn 41, Issue 3, 1996, Pages 205-213

  Van Der Geest, R ^a   Elshove, D A R ^a   Danhof, M ^a   Lavrijsen, A P M ^a   Bodde H E ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Barrier function; Human; In vivo; Iontophoresis; Irritation; Transdermal

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ERYTHEMA; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SAFETY; SKIN; SKIN IRRITATION; SKIN WATER LOSS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030248493     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01329-6     Document Type: Article

References (24)

1. [1] N.H. Yoshida and M.S. Roberts, Structure-transport relationships in transdermal iontophoresis. Adv. Drug Deliv. Rev. 9 (1992) 239-264.
2. [2] D.R. Arenson, K.J. Sonne, P.L. Williams, R.S. Hillman and J.E. Riviere, Comparison of various models for predicting iontophoresis of arbutamine through human skin. Proc. Int. Symp. Control. Release Bioact. Mater. 20 (1993) 434-435.
3. [3] R. Meyer, W. Kreis, J. Eschbach, V. O'Mara, S. Rosen and D. Sibalis, Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharm. Ther. 44 (1988) 607-612.
4. [4] P.W. Ledger, Skin biological issues in electrically enhanced transdermal delivery. Adv. Drug Deliv. Rev. 9 (1992) 289-307.
5. [5] W.H.M. Craane-van Hinsberg, J.C. Verhoef, H.E. Boddé, Transdermal iontophoresis of peptides and proteins, in: Drug Absorption Enhancement. Harwood Acad. Publ. Chur. (1994).
6. [6] C. Prottey, The Molecular Basis of Skin Irritation. Cosmetic Science I, Academic Press, London (1978) pp. 275-349.
7. [7] H.E. Boddé, J. Verhoeven and L.J.M. van Driel, The skin compliance of transdermal drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 6 (1989) 87-115.
8. [8] G.B. Kasting and L.A. Bowman, Electrical analysis of fresh human skin: a comparison with frozen skin. Pharm. Res. 7 (1990) 1141-1145.
9. [9] W.H.M. Craane-van Hinsberg, F. Spies, G.S. Gooris, J.A. Bouwstra, J.C. Verhoef, H.E. Junginger and H.E. Boddé, Electroperturbation of the skin barrier in vitro. II. Effects on stratum corneum resistance and capacitance, on lipid ordering and ultrastructure (submitted for publication).
10. [10] S. Grimes. Dielectric breakdown of human skin in vivo. Med. Biol. Eng. Comput. 21 (1983) 379-381.
11. [11] E. Camel, M. Cross, M. O'Connell, B. Sage and H. Maibach, Effect of iontophoresis on skin irritation in human volunteers. Proc. Int. Symp. Control. Release Bioact. Mater. 20 (1993) 94.
12. [12] S. Thysman, D. van Neste and V. Préat, Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol. 8 (1995) 229-236.
13. [13] K. Okabe, H. Yamaguchi and Y. Kawai, New iontophoretic transdermal administration of the beta-blocker metoprolol. J. Control. Release 4 (1986) 79-85.
14. [14] E. Oestmann, A.P.M. Lavrijsen, J. Hermans and M. Ponec, Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra-and inter-individual variability. Br. J. Dermatol. 128 (1993) 130-136.
15. [15] A.P.M. Lavrijsen, E. Oestman, J. Hermans, H.E. Boddé, B.J. Vermeer and M. Ponec, Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotmate. Br. J. Dermatol. 129 (1993) 547-554.
16. [16] R.A. Tupker, J. Pinnagoda, P.J. Coenraads and J.P. Nater, Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br. J. Dermatol. 123 (1990) 199-205.
17. [17] J. Pinnagoda, R.A. Tupker, T. Agner and J. Serup, Guidelines for transdermal water loss (TEWL) measurement. Contact Dermatitis 22 (1990) 164-178.
18. [18] A. Bircher, E.M. de Boer, T. Agner, J.E. Wahlberg and J. Serup, Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry. Contact Dermatitis 30 (1994) 65-72.
19. [19] P.J. Frosch and A.M. Kligman, The soap chamber test. J. Am. Acad. Dermatol. 1 (1979) 35-41.
20. [20] T. Agner and J. Serup, Time course of occlusive effects on skin evaluated by measurement of transepidermal water loss (TEWL). Contact Dermatitis, 28 (1993) 6-9.
21. [21] A. Kim, P.G. Green, G. Rao and R.H. Guy, Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10 (1993) 1315-1320.
22. [22] S.Y. Oh and R.H. Guy, Effects of iontophoresis on the electrical properties of human skin in vivo. Int. J. Pharm. 124 (1995) 137-142.
23. [23] N.A. Monteiro-Riviere, Altered epidermal morphology secondary to lidocaine iontophoresis: in vivo and in vitro studies in porcine skin. Fundam. Appl. Toxicol. 15 (1990) 174-185.
24. [24] M.J. Pikal and S. Shah, Study of the mechanisms of flux enhancement through hairless mouse skin by pulsed DC iontophoresis. Pharm. Res. 8 (1991) 365-369.